While independent risk factors associated with MACE are difficult to modify since they are intrinsic to the underlying diseases (coronary disease, insulin treatment, transient ischemic attack and heart failure), here we identified statins used as a protective factor that could be used by physicians in clinical practice. The gene discussed is INS; the disease is heart failure.